Redmile Group

Investor type

VC

Founded

2007

AUM

$6 500 M

Location

San Francisco, California, United States

Investment Ticket

$0-1 m

Investment Stage

Seed Series B Series A

Region of investment

North America Europe
Investor profile last updated: 16 August, 2026

Profile

Redmile Group is a company based out of San Francisco.

Redmile Group is a hedge fund and private equity management company that does venture investments, private equity, and post IPO equity investments in the healthcare industry. The company was founded in 2007 and is based in San Francisco, California. It focuses on biotechnology, healthcare, therapeutics, life sciences, and the medical devices sector. The firm has invested in companies like AlloVir, IGM Biosciences, Saluda Medical, Repare Therapeutics, ArcherDX, Augmedix, and BioNTech. As of January 2020, the firm has had 38 exits.

Industry

Fashion/Beauty Healthcare Services Other Software Transportation HealthTech Biotechnology Medical Devices Pharmaceuticals Life Sciences

Redmile Group Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Redmile Growth Investments I LP
Venture Capital (VC)
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
Life Sciences
Seed
Series A
North America
$5-10 m
$157 M
February 2022

Contacts

Name
Title
Email
avatar
Ming Fang Managing Director
Managing Director
m•••@•••
avatar
Laura Feinleib Investment Associate
Investment Associate
l•••@•••
Upgrade to see contacts
avatar
wCpVakiuY6bty4nq wCpVakiuY6bty4nq
wCpVakiuY6bty4nq
avatar
wCpVakiuY6bty4nq wCpVakiuY6bty4nq
wCpVakiuY6bty4nq
avatar
wCpVakiuY6bty4nq wCpVakiuY6bty4nq
wCpVakiuY6bty4nq
Investment-team contacts for Redmile Group — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Redmile Group

Redmile Group is a venture capital firm. It backs companies at Seed, Series B and Series A, writing tickets of $0-1 m.
Redmile Group is located in San Francisco, California, United States.
Redmile Group was founded in 2007.
Redmile Group invests in companies and startups in Fashion/Beauty, Healthcare Services, Other, Software, Transportation, HealthTech, Biotechnology, Medical Devices, Pharmaceuticals, Life Sciences.
Redmile Group invests in companies and startups in North America, Europe.
Redmile Group invests in companies and startups at Seed, Series B, Series A.
Redmile Group usually invests $0-1 m on average.
Redmile Group has around $6 500m assets under management.
Redmile Group last fund was created/launched in 2022-02-09
Redmile Group can be reached through its website redmilegroup.com and its LinkedIn page. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Redmile Group — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Redmile Group directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.